XML 17 R6.htm IDEA: XBRL DOCUMENT v3.21.2
Consolidated Statements of Stockholders' Equity - USD ($)
$ in Thousands
Common Stock [Member]
Additional Paid-in Capital [Member]
Treasury Stock [Member]
Retained Earnings [Member]
Accumulated Other Comprehensive Income (Loss) [Member]
Total
Cumulative Effect, Period of Adoption, Adjustment [Member]
Treasury Stock [Member]
Cumulative Effect, Period of Adoption, Adjustment [Member]
Retained Earnings [Member]
Cumulative Effect, Period of Adoption, Adjustment [Member]
Accumulated Other Comprehensive Income (Loss) [Member]
Cumulative Effect, Period of Adoption, Adjustment [Member]
Balance at Dec. 31, 2018 $ 25 $ 4,267 $ (9,038) $ 64,476 $ (1,444) $ 58,286        
Balance (Accounting Standards Update 2016-02 [Member]) at Dec. 31, 2018             $ 0 $ (362) $ 0 $ (362)
Balance (in shares) at Dec. 31, 2018           9,060,561        
Increase (Decrease) in Stockholders' Equity [Roll Forward]                    
Stock-based compensation expense 0 186 0 0 0 $ 186        
Issuance of restricted stock $ 0 0 0 0 0 0        
Issuance of restricted stock (in shares) 1,408                  
Purchase of treasury stock $ 0 0 $ (715) 0 0 (715)        
Purchase of treasury stock (in shares)     (127,945)              
Net income (loss) 0 0 $ 0 1,520 0 1,520        
Foreign currency translation adjustments, net of tax 0 0 0 0 314 314        
Balance at Mar. 31, 2019 25 4,453 (9,753) 65,634 (1,130) $ 59,229        
Balance (in shares) at Mar. 31, 2019           8,934,024        
Balance at Dec. 31, 2018 25 4,267 (9,038) 64,476 (1,444) $ 58,286        
Balance (Accounting Standards Update 2016-02 [Member]) at Dec. 31, 2018             $ 0 $ (362) $ 0 $ (362)
Balance (in shares) at Dec. 31, 2018           9,060,561        
Increase (Decrease) in Stockholders' Equity [Roll Forward]                    
Net income (loss) [1]           $ (1,074)        
Foreign currency translation adjustments, net of tax           205        
Balance at Sep. 30, 2019 25 4,837 (9,773) 63,040 (1,239) $ 56,890        
Balance (in shares) at Sep. 30, 2019           8,930,187        
Balance at Mar. 31, 2019 25 4,453 (9,753) 65,634 (1,130) $ 59,229        
Balance (in shares) at Mar. 31, 2019           8,934,024        
Increase (Decrease) in Stockholders' Equity [Roll Forward]                    
Stock-based compensation expense 0 192 0 0 0 $ 192        
Purchase of treasury stock 0 0 $ (9) 0 0 (9)        
Purchase of treasury stock (in shares)     (1,800)              
Net income (loss) 0 0 $ 0 (875) 0 (875)        
Foreign currency translation adjustments, net of tax 0 0 0 0 87 87        
Balance at Jun. 30, 2019 25 4,645 (9,762) 64,759 (1,043) $ 58,624        
Balance (in shares) at Jun. 30, 2019           8,932,224        
Increase (Decrease) in Stockholders' Equity [Roll Forward]                    
Stock-based compensation expense 0 192 0 0 0 $ 192        
Purchase of treasury stock 0 0 $ (11) 0 0 (11)        
Purchase of treasury stock (in shares)     (2,037)              
Net income (loss) 0 0 $ 0 (1,719) 0 (1,719) [1]        
Foreign currency translation adjustments, net of tax 0 0 0 0 (196) (196)        
Balance at Sep. 30, 2019 25 4,837 (9,773) 63,040 (1,239) $ 56,890        
Balance (in shares) at Sep. 30, 2019           8,930,187        
Balance at Dec. 31, 2019 25 5,037 (9,773) 62,211 (1,081) $ 56,419        
Balance (in shares) at Dec. 31, 2019           9,022,187        
Increase (Decrease) in Stockholders' Equity [Roll Forward]                    
Stock-based compensation expense 0 228 0 0 0 $ 228        
Issuance of restricted stock $ 0 0 0 0 0 0        
Issuance of restricted stock (in shares) 20,804                  
Net income (loss) $ 0 0 0 (1,738) 0 (1,738)        
Foreign currency translation adjustments, net of tax 0 0 0 0 (346) (346)        
Balance at Mar. 31, 2020 25 5,265 (9,773) 60,473 (1,427) $ 54,563        
Balance (in shares) at Mar. 31, 2020           9,042,991        
Balance at Dec. 31, 2019 25 5,037 (9,773) 62,211 (1,081) $ 56,419        
Balance (in shares) at Dec. 31, 2019           9,022,187        
Increase (Decrease) in Stockholders' Equity [Roll Forward]                    
Net income (loss) [1]           $ (4,495)        
Foreign currency translation adjustments, net of tax           (83)        
Balance at Sep. 30, 2020 25 5,666 (9,773) 57,716 (1,164) $ 52,470        
Balance (in shares) at Sep. 30, 2020           9,042,991        
Balance at Mar. 31, 2020 25 5,265 (9,773) 60,473 (1,427) $ 54,563        
Balance (in shares) at Mar. 31, 2020           9,042,991        
Increase (Decrease) in Stockholders' Equity [Roll Forward]                    
Stock-based compensation expense 0 183 0 0 0 $ 183        
Net income (loss) 0 0 0 (1,775) 0 (1,775)        
Foreign currency translation adjustments, net of tax 0 0 0 0 130 130        
Balance at Jun. 30, 2020 25 5,448 (9,773) 58,698 (1,297) $ 53,101        
Balance (in shares) at Jun. 30, 2020           9,042,991        
Increase (Decrease) in Stockholders' Equity [Roll Forward]                    
Stock-based compensation expense 0 218 0 0 0 $ 218        
Net income (loss) 0 0 0 (982) 0 (982) [1]        
Foreign currency translation adjustments, net of tax 0 0 0 0 133 133        
Balance at Sep. 30, 2020 $ 25 $ 5,666 $ (9,773) $ 57,716 $ (1,164) $ 52,470        
Balance (in shares) at Sep. 30, 2020           9,042,991        
[1] For the three and nine months ended September 30, 2020, there were 1,875 and 7,422 shares, respectively, excluded from the diluted EPS calculation and for the three and nine months ended September 30, 2019, there were 2,704 and 5,200 shares, respectively excluded from the diluted EPS calculation because the impact of their assumed vesting would be anti-dilutive due to a net loss in those respective periods.